ORal IrON Supplementation With Ferric Maltol in Patients With Heart Failure Carrying Left Ventricular Assist Devices

Summary

This is a open-label, uncontrolled, monocenter, phase IV study. The aim of this study is to detect AEs or SAEs with a relative frequency of at least 11.5% in LVAD patients with iron deficiency anemia treated with oral ferric maltol for 12 weeks.

Timeline

Start

2019-03-18

Primary completion

2019-11-29

Completion

2019-11-29

Outcome

Outcome not reported

Stopped (Enrollment): “low recruitment rate; difficulties to achieve planned number of participants within reasonable time frame”

Drugs

Indications